Jasper Therapeutics Inc. (NASDAQ: JSPR)
$21.15
-0.4500 ( -2.08% ) 94.2K
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
Market Data
Open
$21.15
Previous close
$21.60
Volume
94.2K
Market cap
$318.46M
Day range
$20.72 - $22.15
52 week range
$4.00 - $31.01
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 2 | Jun 10, 2024 |
4 | Insider transactions | 1 | Jun 10, 2024 |
4 | Insider transactions | 2 | Jun 10, 2024 |
4 | Insider transactions | 2 | Jun 10, 2024 |
10-q | Quarterly Reports | 74 | May 14, 2024 |
def | Proxies and info statements | 3 | Apr 22, 2024 |
ars | Annual reports | 1 | Apr 22, 2024 |
4 | Insider transactions | 1 | Mar 12, 2024 |
10-k | Annual reports | 100 | Mar 05, 2024 |
8-k | 8K-related | 17 | Mar 04, 2024 |